Mesenbio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.78M
- Investors
-
5
Mesenbio General Information
Description
Developer of exosome-based therapeutics designed to treat inflammatory and degenerative diseases. The company offers engineered extracellular vesicles with targeted delivery and scalable manufacturing, focusing on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translating the body of work into cutting-edge therapeutics, enabling pharmaceutical companies and healthcare providers to access advanced therapies for patients in immunology and regenerative medicine.
Contact Information
Website
www.mesenbio.netCorporate Office
- University of York Wentworth Way
- Department of Biology
- York YO10 5DD
- England, United Kingdom
Corporate Office
- University of York Wentworth Way
- Department of Biology
- York YO10 5DD
- England, United Kingdom
Mesenbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 09-Jan-2024 | $1.78M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 11-Oct-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 06-Dec-2021 | Completed | Generating Revenue |
Mesenbio Signals
Mesenbio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DSW Ventures | Venture Capital | Minority | ||
| NG Bio (UK) | Venture Capital | Minority | ||
| SETsquared Partnership | Accelerator/Incubator | |||
| University of York | University | |||
| ICURe | Accelerator/Incubator |
Mesenbio FAQs
-
When was Mesenbio founded?
Mesenbio was founded in 2021.
-
Where is Mesenbio headquartered?
Mesenbio is headquartered in York, United Kingdom.
-
What is the size of Mesenbio?
Mesenbio has 6 total employees.
-
What industry is Mesenbio in?
Mesenbio’s primary industry is Drug Discovery.
-
Is Mesenbio a private or public company?
Mesenbio is a Private company.
-
What is Mesenbio’s current revenue?
The current revenue for Mesenbio is .
-
How much funding has Mesenbio raised over time?
Mesenbio has raised $1.78M.
-
Who are Mesenbio’s investors?
DSW Ventures, NG Bio (UK), SETsquared Partnership, University of York, and ICURe have invested in Mesenbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process